Details for Patent: 6,858,228

Title:	Solid oral dosage forms of valsartan
Abstract:	The present invention is concerned with solid oral dosage forms of comprising a) an active agent selected from valsartan and optionally HCTZ, and b) Pharmaceutically acceptable additives suitable for the preparation of solid oral dosage forms by compression methods.
Inventor(s):	Katakuse; Yoshimitsu (Hirakata, JP), Kohlmeyer; Manfred (Basel, CH), Taike; Takashi (Kobe, JP), Wagner; Robert Frank (Neshanic Station, NJ), Yamato; Fujiki (Takarazuka, JP)
Assignee:	Novartis AG (Basel, CH)
Filing Date:	Sep 20, 2002
Application Number:	10/251,009
Claims:	1. A compressed solid oral dosage form comprising: a) an active agent containing an effective amount of valsartan or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable additive wherein the active agent is present in an amount of more than 35% by weight based on the total weight of the compressed solid oral dosage form, said solid oral dosage form comprising: 2. A compressed solid oral dosage form according to claim 1 wherein said dosage from exhibits accelerated release of the active agent. 3. A compressed solid oral dosage form comprising: a) an active agent containing an effective amount of valsartan or a pharmaceutically acceptable salt thereof and b) at least one pharmaceutically acceptable additive wherein the active agent is present in an amount of more than 35% by weight based on the total weight of the compressed solid oral dosage form, said solid oral dosage form comprising: 4. The compressed solid oral dosage form according to claim 3 wherein said dosage form exhibits accelerated release of the active agent. 5. A compressed solid oral dosage form comprising: a) an active agent containing an effective amount of valsartan or a pharmaceutically acceptable salt thereof and b) at least one pharmaceutically acceptable additive wherein the active agent is present in an amount of more than 35% by weight based on the total weight of the compressed solid oral dosage form, said solid oral dosage form comprising: 6. The compressed solid oral dosage form according to claim 5 wherein said dosage form exhibits accelerated release of the active agent.